GlassScriptPhysician profile
Muhammad Umer Tariq
NPI 1124374939
$16,039.51
in general payments reported to CMS, 2019-2025
31 companies · $1,822 in 2025
The $1,822 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $499 · 2021: $640 · 2022: $1,279 · 2023: $1,686 · 2024: $9,722 · 2025: $1,822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,997 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,750 · Travel and Lodging: $3,385 · Education: $98.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,997.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,750.00 |
| Travel and Lodging | $3,385.42 |
| Education | $98.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $8,667.62 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $1,634.06 | 2019-2025 | Impella |
| Boston Scientific Corporation | $1,169.67 | 2020-2025 | Avvigo Guidance System, Rotablator Rotational Atherectomy System Console Kit, Synergy |
| Abbott Laboratories | $978.32 | 2019-2025 | Diamondback Coronary, Optis, Na |
| E.R. Squibb & Sons, L.L.C. | $495.06 | 2022-2025 | Camzyos, Eliquis |
| Recor Medical INC | $392.44 | 2024-2025 | Paradise Renal Denervation System, Paradise Ultrasound Renal Denervation System |
| Novartis Pharmaceuticals Corporation | $352.35 | 2020-2025 | |
| Shockwave Medical, INC | $300.20 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $290.91 | 2019-2024 | Repatha |
| Medtronic, INC. | $286.48 | 2022-2024 | Symplicity G3 |
| Stryker Corporation | $264.18 | 2025 | Flowtriever |
| Pfizer INC. | $126.70 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $124.19 | 2019-2023 | Xarelto |
| Penumbra, INC. | $124.17 | 2019-2021 | |
| Cardiovascular Systems INC. | $119.71 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $113.68 | 2021-2022 | |
| Medtronic Vascular, INC. | $86.19 | 2019 | |
| Merck Sharp & Dohme LLC | $63.97 | 2022 | |
| Edwards Lifesciences Corporation | $61.34 | 2024-2025 | Sapien 3 Ultra Resilia, Pascal |
| Irhythm Technologies, INC. | $60.45 | 2023 | Zio Xt Patch |
| Chiesi USA, INC. | $56.49 | 2021-2023 | Cleviprex, Kengreal |
| Astrazeneca Pharmaceuticals LP | $49.12 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $46.33 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.14 | 2022-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.02 | 2022 | |
| Terumo Medical Corporation | $26.06 | 2021 | |
| Astellas Pharma US INC | $21.37 | 2021 | |
| Daiichi Sankyo INC. | $19.32 | 2023 | Injectafer |
| Bardy Diagnostics, INC. | $15.00 | 2021 | |
| Cook Medical LLC | $14.82 | 2019 | |
| Teleflex LLC | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Tariq listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.